InGen Corporate Resolution 213C was the decision, made in December 1996, was the decision to remove Dr. John P. A. Hammond as CEO and President of International Genetic Technologies, Inc. effective May 26, 1997. He was succeeded by Peter Ludlow, who served in official capacity as CEO for slightly more than three days before dying.